JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v6i2.3578ArticleExperience of Treating Hypertension from Liver and Spleen Among Middle-Aged and Young Patients: A Summaryhttps://artdesignp.com/journal/JCNR/6/2/10.26689/jcnr.v6i2.3578LiCaiying2022622022-01-20Qi deficiency of the spleen and stomach, transportation, phlegm and dampness generate endogenous and turbid phlegm that violates the position of yang clearance. As a result, dizziness cis resulted. The author believes that the incidence of middle-aged and young patients with hypertension is mostly related to the dysfunction of liver and spleen. Liver depression and qi stagnation is the beginning of the onset; spleen deficiency and dyskinesia is the norm of the onset; and liver and spleen imbalance is the origin of the onset. It is advocated that regulating the liver and spleen to restore the rise and fall, harmonizing qi and blood and preventing lesions are the main treatment methods for the treatment of middle-aged and young people’s hypertension, which is conducive to the development of more clinical diagnosis and treatment ideas for hypertension amomg middle-aged and young people.

Liu J, Lu Xi, Chen L, et al., 2020, Expert Consensus on Hypertension Management of Young and Middle-aged People in China. Chinese Journal of Hypertension, 28(04): 316–324.

Fang X, Pan X, Cheng Y, et al., 2020, Interpretation of “Chinese Expert Consensus on Hypertension Management for Young and Middle-aged People”. Chinese Journal of Evidence-Based Medicine, 20(07): 753–758.

De VT, Lu M, Figueredo VM, 2016, Hypertension in Young Adults. Postgrad Med, 128(2): 201–207.

Meng X, Xiong X, 2020, Understanding of Traditional Chinese Medicine of Incipient Hypertension and Youth Hypertension and Clinical Treatment Experience of Tianma Uncaria Decoction. China Journal of Chinese Materia Medica, 45(12): 2752–2759.

Wang Y, Wang H, Ma M, et al., 2020, Study on the Prevalence and Influencing Factors of Hypertension in Young People. Molecular Cardiology of China, 20(05): 3550–3553.